Leukemia, Myelomonocytic, Acute
"Leukemia, Myelomonocytic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.
| Descriptor ID |
D015479
|
| MeSH Number(s) |
C04.557.337.539.520
|
| Concept/Terms |
Leukemia, Myelomonocytic, Acute- Leukemia, Myelomonocytic, Acute
- Leukemia, Myeloid, Naegeli-Type
- Myeloid Leukemia, Naegeli-Type
- Leukemia, Naegeli-Type Myeloid
- Myeloid Leukemia, Naegeli Type
- Naegeli-Type Myeloid Leukemia
- Myelomonocytic Leukemia, Acute
- Acute Myelomonocytic Leukemia
- Acute Myelomonocytic Leukemias
- Leukemia, Acute Myelomonocytic
- Leukemias, Acute Myelomonocytic
- Myelomonocytic Leukemias, Acute
- Leukemia, Myeloid, Acute, M4
- Myeloid Leukemia, Acute, M4
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myelomonocytic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myelomonocytic, Acute".
This graph shows the total number of publications written about "Leukemia, Myelomonocytic, Acute" by people in this website by year, and whether "Leukemia, Myelomonocytic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Myelomonocytic, Acute" by people in Profiles.
-
Discovery of proangiogenic CD44+mesenchymal cancer stem cells in an acute myeloid leukemia patient's bone marrow. J Hematol Oncol. 2020 06 03; 13(1):63.
-
Acute myelomonocytic leukemia with histologic features resembling sarcomatoid carcinoma in bone marrow. Arch Pathol Lab Med. 2000 Feb; 124(2):315-8.
-
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology. Ann Oncol. 1999 Nov; 10(11):1355-9.